ACXP
Acurx Pharmaceuticals
Acurx Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Company Sector
Small Molecule Drugs
39 companies tagged with Small Molecule Drugs.
Small Molecule Drugs includes companies developing orally available or otherwise chemically synthesized medicines built from relatively low-molecular-weight compounds. This remains one of the broadest and most commercially important categories in biotech and pharma.
FOLD
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ARDX
Ardelyx
Ardelyx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ARVN
Arvinas, Inc.
Arvinas is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
AZN
AstraZeneca PLC
AstraZeneca is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BCYC
Bicycle Therapeutics
Bicycle Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
BCRX
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
BMEA
Biomea Fusion
Biomea Fusion is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
CCCC
C4 Therapeutics
C4 Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CDXI
Cardax Pharma
Cardax Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CRVS
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CRIS
Curis Inc
Curis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
DICE
DICE
DICE is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
DFFN
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
LLY
Eli Lilly
Eli Lilly is a large-cap pharmaceutical company with major exposure to cardiometabolic disease, neuroscience, and oncology. Investors track the stock for commercial scale, label expansion, and a pipeline that still carries meaningful growth optionality.
ENTA
Enanta Pharmaceuticals
Enanta Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
EPIX
ESSA Pharma
ESSA Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
EXEL
Exelixis
Exelixis is an oncology-focused biopharmaceutical company best known for its established commercial base and continued pipeline work in cancer. Investors follow the stock for launch durability and the next wave of oncology catalysts.
FGEN
FibroGen
FibroGen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
FULC
Fulcrum Therapeutics
Fulcrum Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
GTHX
G1 Therapeutics
G1 Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
GSK
GSK plc
GSK plc is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
IKT
Inhibikase Therapeutics
Inhibikase Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
INVA
Innoviva
Innoviva is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
JNJ
Johnson & Johnson
Johnson & Johnson is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
KALV
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
KURA
Kura Oncology
Kura Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
KYMR
Kymera
Kymera is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
MNOV
MediciNova
MediciNova is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
NRIX
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
OCUP
Ocuphire
Ocuphire is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
OMER
Omeros
Omeros is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
PMVP
PMV Pharmaceuticals
PMV Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
TERN
Terns Pharmaceuticals
Terns Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
VTYX
Ventyx Biosciences, Inc.
Ventyx Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
VRTX
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a commercial-stage biotech company best known for a durable launch franchise and a pipeline that still carries meaningful optionality. Investors pay close attention to how the company expands beyond its core commercial base.
VTRS
Viatris Inc.
Viatris is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
XFOR
X4 Pharmaceuticals
X4 Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ZNTL
Zentalis
Zentalis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.